PharmiWeb.com - Global Pharma News & Resources

Research and development - Press Releases

Date Title Company
21-Oct-2023 Maximizing Therapeutic Potential: CD Formulation's Versatile Drug Delivery Systems Advance Pharmacokinetics and Pharmacodynamics CD Formulation
20-Oct-2023 Alfa Chemistry Newly Launches IVD Products for Laboratory Use Alfa Chemistry
20-Oct-2023 CD Formulation’s Physical Parameter Determination: A Crucial Step in Pharmaceutical Analysis and Testing CD Formulation
19-Oct-2023 Securing the Integrity of Microneedle Structure Design and Optimization: CD Formulation's Performance Testing Approach CD Formulation
17-Oct-2023 Discovery Park and Researcher partner to support scientific collaboration Discovery Park
17-Oct-2023 CD BioSciences Launches New 3D Tissue Imaging Services CD BioSciences
17-Oct-2023 HighRun DataScience Launches Data Science Platform for Global Customers HighRun DataScience
17-Oct-2023 CD BioSciences Launches New Services to Study Catabolism in Diabetes CD BioSciences
16-Oct-2023 ‘Strategic alliances’ in pharma and biotech: innovation through cooperation Bachem
16-Oct-2023 Navin Fluorine International Ltd. launches Navin Molecular: The new brand for its future-thinking CDMO business Navin Molecular
12-Oct-2023 CD Bioparticles Launches 3D Cell Culture Substrate for Bio-research CD Bioparticles
12-Oct-2023 STEMart Announces Rapid Endotoxin Testing Services for Medical Devices STEMart
10-Oct-2023 Creative Diagnostics Launches New Azaperone Test Reagents for Research Applications Creative Diagnostics
10-Oct-2023 Creative Diagnostics Launches Checkerboard Assay Services Creative Diagnostics
10-Oct-2023 Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facilitate NALFIA Development Creative Diagnostics
09-Oct-2023 Sygnature Discovery collaborates with Axol Bioscience to utilize human iPSC-derived microglial cells in high-content imaging drug discovery screening workflows Sygnature Discovery
05-Oct-2023 Veranova Announces Appointment of New Advisory Board Veranova
05-Oct-2023 Gens & Associates launches latest World Class RIM℠ study – the largest yet – to define & hone “industry standard” practice Gens & Associates
04-Oct-2023 NEW DEVELOPMENT IN THE TREATMENT OF ALZHEIMER’S DISEASE Luye Pharma Ltd
03-Oct-2023 Oxford BioTherapeutics Announces Partner Boehringer Ingelheim Received U.S. FDA Fast Track Designation for BI 764532 for the Treatment of Extensive Stage Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancers Oxford BioTherapeutics